Quick Dispatch:
Your roche glp-1 Roche plans to become top 3 obesity player as CT-388 enters trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your roche glp-1 Roche plans to become top 3 obesity player as CT-388 enters trial ships.
Need Help?
Questions about roche glp-1 Roche plans to become top 3 obesity player as CT-388 enters trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for roche glp-1 Roche plans to become top 3 obesity player as CT-388 enters trial in your area.
How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments
29.66
Roche Oral GLP-1 Agonist Scores in Early Trial
23.98
Roche, trailing in obesity, showcases new data for GLP-1 shot
22.43
Food For Thought: The Potential Ripple Effect of GLP1s
29.02
⚡️ 𝗥𝗼𝗰𝗵𝗲 𝗷𝘂𝘀𝘁 𝗽𝗼𝘀𝘁𝗲𝗱 𝗣𝗵𝗮𝘀𝗲 𝟮 𝗼𝗯𝗲𝘀𝗶𝘁𝘆 𝗱𝗮𝘁𝗮 𝘁𝗵𝗮𝘁 𝗿𝗶𝘃𝗮𝗹 𝗭𝗲𝗽𝗯𝗼𝘂𝗻𝗱... 𝗬𝗲𝗮𝗿𝘀 𝗹𝗮𝘁𝗲 𝘁𝗼 𝗮 $𝟭𝟬𝟬𝗕 𝗿𝗮𝗰𝗲. Roche has released Phase 2 results for CT-388, a dual GLP-1/GIP injectable obesity
26.57
Readout Newsletter: Roche, Vertex, and J.D. Vance updates
26.98
Roche's Genentech vows to expand NC anti-obesity drug plant
29.16
